Search results for: 'saudi drugs share'

With electronics integrating into customers’ daily lives, companies need to invest in the innovation of form and software to move beyond traditionally shaped devices and capture market share. This study explores the various innovations in form factors that companies are currently developing and are expected to develop between 2022 to 2030 to remain...

Curbsides are becoming the next battleground for cities, primarily because the use of curbside spaces is no longer restricted to parking. They now include eHailing vehicles dropping and picking up customers, delivery vehicles dropping off and picking up packages. Microtransit assets, such as bikes and scooters now occupy the sidewalk. Cities do not...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

This edition of Trend Opportunity Profiles features trend advancements in health, wellness, and nutrition featuring fitness as a service, nootropics, advancements in bionics, cultured meat, sustainable nourishment, obesity drugs, synthetic skin, and virtual nursing. Frost & Sullivan's Trend Opportunity Profiles series covers specific opportuniti...

06 Feb 2018  |  Global  |  Market Research

Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows

Infographics

×

Key Issues Addressed

The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe. Increasing clinical trial activities in the emerging Asia-Pacific markets and r...

02 Feb 2017  |  Europe  |  Market Research

European Next-generation Sequencing Services Market, Forecast to 2023

Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

Infographics

×

The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-changing Compa...

Frost and Sullivan expects 2023 to be the year of resilience. Businesses will face a range of challenges, including a global economic slowdown, supply chain bottlenecks, and geopolitical shocks. Organizations of all sizes and types will be compelled to find new areas for growth, despite an abrupt downturn in consumer demand. This study identifi...